121 related articles for article (PubMed ID: 34405092)
1. Successful Treatment of Persistent Coronavirus Disease 2019 Infection in a Patient With Hypogammaglobulinemia With REGN-COV2: A Case Report.
Luitel P; Vais D; Gidron A
Open Forum Infect Dis; 2021 Aug; 8(8):ofab335. PubMed ID: 34405092
[TBL] [Abstract][Full Text] [Related]
2. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.
Taha Y; Wardle H; Evans AB; Hunter ER; Marr H; Osborne W; Bashton M; Smith D; Burton-Fanning S; Schmid ML; Duncan CJA
Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):85. PubMed ID: 34969393
[TBL] [Abstract][Full Text] [Related]
3. Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.
Phan AT; Gukasyan J; Arabian S; Wang S; Neeki MM
Cureus; 2021 May; 13(5):e15280. PubMed ID: 34194882
[TBL] [Abstract][Full Text] [Related]
4. REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan.
Sakurai A; Marshall S; Ogasawara T; Ogasawara T; Aoka Y; Sakura H; Uchigata Y; Ogawa T
J Infect Chemother; 2022 Jul; 28(7):943-947. PubMed ID: 35414436
[TBL] [Abstract][Full Text] [Related]
5. Real world utilization of REGEN-COV2 at a community hospital.
Ash J; Leavitt R; Dietrich T; Schritter S; Wells J; Santarelli A; Ashurst J
Am J Emerg Med; 2021 Dec; 50():129-131. PubMed ID: 34364110
[TBL] [Abstract][Full Text] [Related]
6. Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity.
Nguyen H; Salkeld J; Agarwal S; Goodman A
Clin Infect Pract; 2021 Nov; 12():100089. PubMed ID: 34426799
[TBL] [Abstract][Full Text] [Related]
7. Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.
Markovitz NH; Pedersen E; Sachs DL; Bresler SC
JAAD Case Rep; 2022 Sep; 27():156-158. PubMed ID: 35845347
[No Abstract] [Full Text] [Related]
8. Clinical Effectiveness of REGN-COV2 in Patients with COVID-19 in Japan: A Retrospective Cohort Study with a Bayesian Inference.
Amano N; Iwata K; Iwata S
Infect Chemother; 2021 Dec; 53(4):767-775. PubMed ID: 34979607
[TBL] [Abstract][Full Text] [Related]
9. Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients.
Liu EC; Lee JH; Loo A; Mazur S; Sultan S; Aull M; Lee JB; Muthukumar T; Hartono C
Kidney Int Rep; 2021 Nov; 6(11):2900-2902. PubMed ID: 34514186
[No Abstract] [Full Text] [Related]
10. Clinical Prognosis of Patients With Mild COVID-19 Treated With Casirivimab/Imdevimab in Japan.
Osugi Y; Iwata H; Imai Y; Kobayashi D; Hirashima R
Cureus; 2022 Feb; 14(2):e21882. PubMed ID: 35273850
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
Singh S; Zuwasti U; Haas C
Cureus; 2020 Nov; 12(11):e11310. PubMed ID: 33282586
[TBL] [Abstract][Full Text] [Related]
12. Hypogammaglobulinemia following COVID-19 infection in a patient on maintenance rituximab.
O'Bryan C; Espinosa R; Chittivelu S
SAGE Open Med Case Rep; 2021; 9():2050313X211065791. PubMed ID: 34925841
[TBL] [Abstract][Full Text] [Related]
13. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options.
Heustess AM; Allard MA; Thompson DK; Fasinu PS
Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071185
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
15. Post-COVID-19 arthritis: a case report and literature review.
Gasparotto M; Framba V; Piovella C; Doria A; Iaccarino L
Clin Rheumatol; 2021 Aug; 40(8):3357-3362. PubMed ID: 33587197
[TBL] [Abstract][Full Text] [Related]
16. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.
Awada H; Nassereldine H; Hajj Ali A
J Med Case Rep; 2021 Jul; 15(1):382. PubMed ID: 34271967
[TBL] [Abstract][Full Text] [Related]
17. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
Islam B; Ahmed M; Islam Z; Begum SM
Skelet Muscle; 2021 Apr; 11(1):10. PubMed ID: 33883014
[TBL] [Abstract][Full Text] [Related]
18. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.
Szabolcs M; Sauter JL; Frosina D; Geronimo JA; Hernandez E; Selbs E; Rapkiewicz AV; Rekhtman N; Baine MK; Jäger E; Travis WD; Jungbluth AA
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):5-12. PubMed ID: 33086222
[TBL] [Abstract][Full Text] [Related]
19. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience.
Diurno F; Numis FG; Porta G; Cirillo F; Maddaluno S; Ragozzino A; De Negri P; Di Gennaro C; Pagano A; Allegorico E; Bressy L; Bosso G; Ferrara A; Serra C; Montisci A; D'Amico M; Schiano Lo Morello S; Di Costanzo G; Tucci AG; Marchetti P; Di Vincenzo U; Sorrentino I; Casciotta A; Fusco M; Buonerba C; Berretta M; Ceccarelli M; Nunnari G; Diessa Y; Cicala S; Facchini G
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):4040-4047. PubMed ID: 32329881
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus and novel coronavirus (SARS-Cov2) coinfection: A case report.
Motta JC; Gómez CC
IDCases; 2020; 22():e00936. PubMed ID: 32864341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
